companydata.dkInnosurge Biologics A/S: Financial statements 2019
CVR: 38768964
Innosurge Biologics A/S (CVR 38768964) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,241,663 and a net result of DKK 290,106 compared with DKK 799,342 the year before. That is a decrease of 28.7% compared with the year before. Equity amounted to DKK 2,049,997. The solvency ratio was 47.9%. The company had 2 employees in the financial year.
- Gross Profit
- 1,241,663 kr.
- Profit/Loss
- 290,106 kr.
- Equity
- 2,049,997 kr.
- Total Assets
- 4,283,713 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.2 mio. | 290 t. | 2 mio. | 2 |
| 2018 | - | 1.7 mio. | 799 t. | 1.8 mio. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
Innosurge Biologics A/S has published its annual report for 2018. Gross profit came to DKK 1,740,667, and the net result was DKK 799,342.
About Innosurge Biologics A/S
Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.